Insider Sale: Director Matthew Posard Sells Shares of Halozyme Therapeutics Inc (HALO)

By Yahoo! Finance | Jun 13, 2024 at 07:06 PM EST

Halozyme Therapeutics Inc is a biopharmaceutical company focusing on oncology therapies targeting the tumor microenvironment. Insider transactions show 17 sells and no buys in the past year. Shares valued at $50.32 with a market cap of $6.315 billion.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.